Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandeep Dutta

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
JACC. Cardiovascular Imaging|August 18, 2012
Prospectively ECG-triggered rapid kV-switching dual-energy CT for quantitative imaging of myocardial perfusionAaron So, Jiang Hsieh, Yasuhiro Imai, et al.
Antimicrobial Agents and Chemotherapy|October 14, 2015
Drug Interactions with the Direct-Acting Antiviral Combination of Ombitasvir and Paritaprevir-RitonavirPrajakta S Badri, Sandeep Dutta, Haoyu Wang, et al.
Journal of Hepatology|June 14, 2015
Pharmacokinetics and safety of co-administered paritaprevir plus ritonavir, ombitasvir, and dasabuvir in hepatic impairmentAmit Khatri, Rajeev M Menon, Thomas C Marbury, et al.
British Journal of Clinical Pharmacology|June 16, 2021
Omecamtiv mecarbil does not prolong QTc intervals at therapeutic concentrationsAshit Trivedi, Cheng-Pang Hsu, Pegah Jafarinasabian, et al.
Antiviral Therapy|September 2, 2016
Effect of co-medications on paritaprevir, ritonavir, ombitasvir, dasabuvir and ribavirin pharmacokinetics: analysis of data from seven Phase II/III trialsAkshanth R Polepally, Prajakta S Badri, Apurvasena Parikh, et al.
BMJ Open|May 28, 2024
Contribution of youth sport participation to physical activity levels and cardiovascular disease risk factors in 5-year-old to 14-year-old children: a study protocol for systematic review and meta-analysisPaola A Fernández Solá, Janette M Watkins, Aidrik Grube, et al.
Journal of Hepatology|February 4, 2015
Drug-drug interaction profile of the all-oral anti-hepatitis C virus regimen of paritaprevir/ritonavir, ombitasvir, and dasabuvirRajeev M Menon, Prajakta S Badri, Tianli Wang, et al.
Frontiers in Public Health|November 30, 2023
Multilevel needs assessment of physical activity, sport, psychological needs, and nutrition in rural children and adultsSarah J Greeven, Andrew M Medellin, Janette M Watkins, et al.
BMC Public Health|March 20, 2024
Human-centered participatory co-design with children and adults for a prototype lifestyle intervention and implementation strategy in a rural middle schoolJanette M Watkins, Sarah J Greeven, Kathleen N Heeter, et al.
Journal of Pharmaceutical Sciences|April 28, 2011
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 1: goals, properties of the PhRMA dataset, and comparison with literature datasetsPatrick Poulin, Hannah M Jones, Rhys Do Jones, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
JACC. Cardiovascular Imaging|August 18, 2012
Prospectively ECG-triggered rapid kV-switching dual-energy CT for quantitative imaging of myocardial perfusionAaron So, Jiang Hsieh, Yasuhiro Imai, et al.
Antimicrobial Agents and Chemotherapy|October 14, 2015
Drug Interactions with the Direct-Acting Antiviral Combination of Ombitasvir and Paritaprevir-RitonavirPrajakta S Badri, Sandeep Dutta, Haoyu Wang, et al.
Journal of Hepatology|June 14, 2015
Pharmacokinetics and safety of co-administered paritaprevir plus ritonavir, ombitasvir, and dasabuvir in hepatic impairmentAmit Khatri, Rajeev M Menon, Thomas C Marbury, et al.
British Journal of Clinical Pharmacology|June 16, 2021
Omecamtiv mecarbil does not prolong QTc intervals at therapeutic concentrationsAshit Trivedi, Cheng-Pang Hsu, Pegah Jafarinasabian, et al.
Antiviral Therapy|September 2, 2016
Effect of co-medications on paritaprevir, ritonavir, ombitasvir, dasabuvir and ribavirin pharmacokinetics: analysis of data from seven Phase II/III trialsAkshanth R Polepally, Prajakta S Badri, Apurvasena Parikh, et al.
BMJ Open|May 28, 2024
Contribution of youth sport participation to physical activity levels and cardiovascular disease risk factors in 5-year-old to 14-year-old children: a study protocol for systematic review and meta-analysisPaola A Fernández Solá, Janette M Watkins, Aidrik Grube, et al.
Journal of Hepatology|February 4, 2015
Drug-drug interaction profile of the all-oral anti-hepatitis C virus regimen of paritaprevir/ritonavir, ombitasvir, and dasabuvirRajeev M Menon, Prajakta S Badri, Tianli Wang, et al.
Frontiers in Public Health|November 30, 2023
Multilevel needs assessment of physical activity, sport, psychological needs, and nutrition in rural children and adultsSarah J Greeven, Andrew M Medellin, Janette M Watkins, et al.
BMC Public Health|March 20, 2024
Human-centered participatory co-design with children and adults for a prototype lifestyle intervention and implementation strategy in a rural middle schoolJanette M Watkins, Sarah J Greeven, Kathleen N Heeter, et al.
Journal of Pharmaceutical Sciences|April 28, 2011
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 1: goals, properties of the PhRMA dataset, and comparison with literature datasetsPatrick Poulin, Hannah M Jones, Rhys Do Jones, et al.
Pageof 12